Tag Archives: Michael Robinson

  • Examining the “One Device to End All Disease… And It Costs Less Than $50” ad from Radical Technology Profits

    That headline might look a little familiar to longtime Gumshoe readers… that’s because Michael Robinson had a very similar ad back in 2013 (and again in 2015) touting MEMS as a “device to end all disease” … … so, is the ad still about the same stock? Let’s look and see. Here’s how the pitch […]

  • “The Next Blockbuster: Insiders are Grabbing This $6 Biotech – You Should, Too” sez Bill Patalon

    This is one of the shorter teaser pitches I’ve ever covered — so, bonus for you, it’s also likelier to be one of my shorter articles! The spiel is an ad for Bill Patalon’s Private Briefing, which is one of those “greatest hits” newsletters … it’s intended to cherry-pick the “best” ideas from all the […]

  • “Help Destroy China’s ‘Internet Army'”

    “Yesterday, I sent you an urgent briefing regarding China’s dangerous “Internet Army.” This situation is already moving fast. “The small tech company critical to crushing China’s attacks just won another contract for an undisclosed “data center”… its third multimillion-dollar contract in less than a month. “This is quickly turning into exactly the kind of win-win […]

  • “How a Secret Global Wire Transfer Could Show You a Potential Tenfold Gain!”

    I’ve written about a number of teasers from Michael Robinson during the couple years he’s been heading up the American Wealth Underground newsletter for Taipan (if that name doesn’t ring a bell, you might remember that this letter used to be the hypetastic BreakAway Investor under Andrew Mickey and others). Robinson is telling us that […]

  • “PANIC AT THE PENTAGON! PLUS: How the Coming Battle for This Resource Could Hand You Gains of 2,106% in as Few as 24 Months”

    Just from that headline, experienced investors and teaser-readers might well know that we’re looking today at rare earth minerals — you might also call them rare earths, rare earth magnets, rare earth elements or lanthanides (they’re usually pulled out of the period table and grouped separately on the bottom if you want the actual names […]

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.